- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 7/02 - Recovery or purification
Patent holdings for IPC class C12N 7/02
Total number of patents in this class: 1082
10-year publication summary
|
38
|
62
|
63
|
49
|
60
|
62
|
51
|
55
|
47
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bavarian Nordic A/S | 263 |
21 |
| The Trustees of the University of Pennsylvania | 4379 |
19 |
| Transgene S.A. | 127 |
10 |
| Cytiva BioProcess R&D AB | 311 |
10 |
| Janssen Vaccines & Prevention B.V. | 305 |
9 |
| Sartorius Stedim Biotech GmbH | 861 |
9 |
| Valneva Austria GmbH | 116 |
9 |
| BIA Separations d.o.o. | 17 |
8 |
| Seqirus UK Limited | 431 |
8 |
| Takeda Vaccines, Inc. | 220 |
8 |
| Novartis AG | 10503 |
7 |
| The Regents of the University of California | 20329 |
7 |
| Kaneka Corporation | 4619 |
7 |
| University of Florida Research Foundation, Inc. | 4098 |
7 |
| The Children's Hospital of Philadelphia | 819 |
7 |
| Crucell Holland B.V. | 87 |
7 |
| Genzyme Corporation | 1323 |
7 |
| Ultragenyx Pharmaceutical Inc. | 184 |
7 |
| uniQure Biopharma B.V. | 92 |
7 |
| uniQure IP B.V. | 86 |
7 |
| Other owners | 901 |